- Home
- SGU vs TECX Comparison
SGU vs TECX Comparison
Compare SGU & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGU
- TECX
- Stock Information
- Founded
- SGU 1995
- TECX 2019
- Country
- SGU United States
- TECX United States
- Employees
- SGU N/A
- TECX N/A
- Industry
- SGU Other Specialty Stores
- TECX
- Sector
- SGU Consumer Discretionary
- TECX
- Exchange
- SGU Nasdaq
- TECX Nasdaq
- Market Cap
- SGU 390.2M
- TECX 387.1M
- IPO Year
- SGU 1995
- TECX 2018
- Fundamental
- Price
- SGU N/A
- TECX $16.09
- Analyst Decision
- SGU
- TECX Buy
- Analyst Count
- SGU 0
- TECX 6
- Target Price
- SGU N/A
- TECX $79.17
- AVG Volume (30 Days)
- SGU 31.9K
- TECX 529.8K
- Earning Date
- SGU 12-03-2025
- TECX 11-06-2025
- Dividend Yield
- SGU 6.34%
- TECX N/A
- EPS Growth
- SGU 33.71
- TECX N/A
- EPS
- SGU 1.66
- TECX N/A
- Revenue
- SGU $1,777,057,000.00
- TECX N/A
- Revenue This Year
- SGU N/A
- TECX N/A
- Revenue Next Year
- SGU N/A
- TECX N/A
- P/E Ratio
- SGU $7.05
- TECX N/A
- Revenue Growth
- SGU N/A
- TECX N/A
- 52 Week Low
- SGU $10.84
- TECX $13.70
- 52 Week High
- SGU $13.75
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- SGU 49.20
- TECX 46.08
- Support Level
- SGU $11.68
- TECX $14.62
- Resistance Level
- SGU $11.90
- TECX $18.03
- Average True Range (ATR)
- SGU 0.18
- TECX 1.14
- MACD
- SGU -0.00
- TECX 0.35
- Stochastic Oscillator
- SGU 44.07
- TECX 44.64
About SGU Star Group L.P.
Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. The company offers heating oil and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.